Basilea Pharmaceutica
BSLN.SW
#6328
Rank
NZ$1.05 B
Marketcap
$86.85
Share price
2.38%
Change (1 day)
13.98%
Change (1 year)

EPS for Basilea Pharmaceutica (BSLN.SW)

EPS in 2023: $1.73

According to Basilea Pharmaceutica's latest financial reports the company's current EPS (TTM) is $1.73. In 2023 the company made an earnings per share (EPS) of $1.73 a decrease over its 2022 EPS that were of $1.84.

EPS history for Basilea Pharmaceutica from 2002 to 2023

Annual EPS

Year EPS Change
2023$1.73-6.28%
2022$1.84-273.94%
2021-$1.06-60.87%
2020-$2.71-24.46%
2019-$3.59-26.92%
2018-$4.9159.83%
2017-$3.07-63.06%
2016-$8.31-19.26%
2015-$10.2946.12%
2014-$7.0410.07%
2013-$6.40-36.76%
2012-$10.12-5.42%
2011-$10.70-153.36%
2010$20.05-198.47%
2009-$20.36-15.34%
2008-$24.0516.7%
2007-$20.6036.07%
2006-$15.1479.07%
2005-$8.46-46.79%
2004-$15.899.83%
2003-$14.47-34.23%
2002-$22.00